NextHen (formerly: Poultry by Huminn) creates and develops scientific breakthroughs to tackle persistent global challenges in health, food production and agriculture.Impact NRS scientists and researchers work collaboratively with leading centers of excellence around the world, including in a joint venture with the Agriculture Research Organization (ARO) – the Ministry of agriculture of the State of Israel.🎯 NextHen is led by industry experts and operates based on a joint venture with the Agriculture Research Organization (ARO) - the Ministry of Agriculture of the State of Israel.🎯 NextHen specializes in the identification through to expression of advantageous phenotypes (traits) of both broilers and layers in the poultry industry. Its flagship project is providing a sustainable, cost-saving way to end the culling of male chicks, by enabling the laying of eggs from which only non-GMO females hatch - the only viable method to end the slaughter of 7 billion chicks each year.🎯 Breeders can now benefit from an increase in production volume and efficiency by freeing up significant incubation space, without any changes to the manufacturing process or additional machinery; Significant cost reduction related to the egg sorting process (human and machine), and accelerating the production process by reducing the volume of eggs transferred into incubators.===✔️ Leading the company towards a winning strategy✔️ Ensuring successful commercialization process✔️ Managing the negotiation on the strategic commercial agreements✔️ Building an exceptional team to lead the industry✉️ We are changing the world as we know it, join us! >>> https://www.nexthen.net

Plantae is a part of Huminn Group, developing sustainable plant-based technology solutions to address unmet needs of health, food production and the environment. Plantae is a convergence of the three most innovative plant biotechnology disciplines available today - Metabolite discovery & pathway design, protein/enzyme predictive design and evolution - with advanced genome editing capabilities.

Huminn (formerly: Impact NRS) creates and commercializes disruptive innovations focused on global health, wellness, and sustainable development challenges.Transforming technologies into platform solutions. Our current venture pipeline includes a highly accurate and cost-efficient platform for cancer diagnosis and breakthrough agricultural technologies developed in Israel that are expected to have a profound impact on the global food chain.Major Portfolio:🔵 Huminn Poultry: applying novel gene-editing applications to produce a lineage of non-GMO poultry with desired features, such as the production of non-GMO all-male roosters for the egg-layer industry, development of non-GMO disease (e.g., avian flu) resistant chickens.🟢 Plantae Bioscience - (Plants) is a science-based company. It is a convergence of the three most innovative plant biotechnology disciplines available today - Metabolite Discovery & Pathways Design, Protein / Enzyme Predictive Design, and evolution with advanced genome-editing capabilities. By harnessing this expertise, Plantae improves technology applications to address the unmet needs of health, food production, and the environment.🟣 RumenEra - (Cow/Bison/Sheep) Microbiome: utilizing patented technologies to precisely and efficiently measure key performance characteristics of all individual herd animals, including those most efficient at converting food into productive protein (milk, meat) while releasing the least amount of methane.===🎯 Managing the NRS Israeli overall operations🎯 Developing business plans, budgets, and strategies in line with NRS vision and implementing these plans, budgets, and strategies🎯 Create and sustain a culture of innovation and enablement, underpinned by and expressing the values and philosophy of NRS🎯 Building the needed teams for NRS several platforms🎯 Leading the executive team to continue building the portfolio companies🎯 Board member in all portfolio companies in Israel

EFA brings the LAB to the BLOOD and not the BLOOD to the LAB without the need for expert preparation.EFA is changing the diagnostics paradigm step by step by enabling tests that were only available in the labs/clinics/hospitals etc. to be done anytime and everywhere.An early and rapid diagnostic is a key to the prevention of overuse and improper medications.Many millions of people cannot access a proper diagnostic due to their medical condition and/or where they live. Bringing as many as possible medical services closer to them will make a huge impact on how we manage health around the world.The initial application of a complete blood count everywhere will give results in less than 5 minutes on the device.WHAT WE DO: A product portfolio company for designing and delivering world-class, affordable, scalable, and sustainable medical-diagnostic solutions to the mass.Based on a talented team, we leverage worldwide collaborations and use innovative technologies and multidisciplinary vast experience.===🎯 Company Board of Directors Member

miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers. Such new standards are urgently needed given the prevalence of these cancers and their debilitating burden globally. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in New York City with operating subsidiaries in Israel, Canada, and Puerto Rico.===✔️ Assembling the miR Scientific Israel team✔️ Leading the miR Scientific Israeli Operations✔️ Crafting a suitable strategy for the Israeli market✔️ Instrumental in developing the relationship with the Israeli HMOs✔️ Facilitating the company set-up for successful penetration into the Israeli market

BioHarvest Founded in 2007 in Rehovot (Israel), developed a unique proprietary (and patented) platform technology capable of growing cells of superfruits and plants in order to produce functional foods that have substantial and clinically proven health benefits, at massive and economic scale.These foods (bio foods) address the growing consumer demand for health and wellness ($84B segment) solutions that are naturally and scientifically based.The company also intends to pursue a botanical drug path for some of its products pending the strength of the scientific dossier and economic viability.🎯 ACCOMPLISHMENTS:✔️ Leading over $22M funding since joining the company, through a network of institutional and high network individual investors✔️ Preparing the company for public listing in US SE including private placement memorandum===🎯 Key business partner to the company CEO and to the Executive Chairman🎯 Build, develop and define overall company strategy🎯 Shaping the appropriate business model based on the company strategy🎯 Created company business plan and articulated to stockholders and investors🎯 Close work with the company external legal adviser on all company legal matters and governance🎯 Assisting the CEO in the company management team building🎯 Set the foundation for business development in the US, South East Asia, and Israel. Creating interactions with major packaged goods companies in the US, including initial collaboration MOUs🎯 Generating the company with business opportunities

BioHarvest is a consumer health care company that has developed a proven, proprietary platform technology currently in commercial-scale production for its maiden product. BioHarvest develops wellness solutions leveraging science and technology to uncover and unleash the power of nature. BioHarvest’s products decouple from their inherent seasonality, variability, geographic inaccessibility, and are devoid of sugar, alcohol, and undesired residues of the parent plant.BioHarvest differentiates from the dietary supplement market because BioHarvest’s breakthrough technology mirrors nature to produce biofood, fruit, or vegetable powder, without any solvent extraction, genetic modification (non-GMO), or synthetic processing.VINIA, the first product for sale to consumers under self-affirmed US GRAS status, is a revolutionary red grape powder that contains the full complex of polyphenols from the red grape (40 mg) and provides many of the benefits associated with the French Paradox phenomenon.===🎯 Identify emerging trends and areas of opportunity for improved profitability🎯 Lead the financial planning and analysis and process to set aggressive yet attainable market targets🎯 Collaborate with executive leadership across the enterprise🎯 Implement process improvements and action plans to drive improved financial performance

Explay is a technology start-up company with leading expertise in the design and development of miniature projectors.The company's product is a projector engine that is small enough to fit inside a mobile device or housed in a separate pocket-size accessory unit that is connected to a mobile device (e.g. cellular phone, digital camera, Personal Media Player, etc.).===🎯 Leading the second round of funding reaching a total of $5M🎯 Creating the business plan, revenue, and expenses projections🎯 Supervising the day-to-day operation of the company🎯 Cultivating the company strategic plan and streamlining the process across the organization

Terayon produced broadband equipment aimed at delivering the most innovative data, video, and voice solutions to service providers.(During 1999-2003, the company also was active in selling telco solutions).The company has been listed on the NASDAQ since 1998 (TERN) and was acquired by Motorola🎯 ACCOMPLISHMENT: Performed more than $75M of sales in the region in 2004-2006.===Responsibilities:🎯 Spearheaded the following activities of the region:🎯 Sales and marketing🎯 Customer support and technical support teams in the region🎯 Managing the partner’s channel in coordination with Corporate Marketing

Directed the telco orientation Business Unit, as a totally independent company. Responsibilities included:🎯 BU sales target 🎯 Direction to R&D 🎯 Production & Manufacturing at Subcontractors facilities 🎯 Sales & Marketing

Led the Finance and IT Divisions in Israel.

Bank Hapoalim is Israel’s largest bank and leading financial group engaged in retail and corporate banking. Operating globally, it is active in major financial centers in Europe, North America and Latin America through 41 branches, subsidiaries, and offices. It focuses on private banking as well as trade, corporate, and syndicated financing.===🎯 Led the Subsidiaries Department in the Controller Division🎯 Managed 25 employees (CPAs and economists)🎯 Responsible for the financial statements of the bank 🎯 Served as a board member of Bank Hapoalim investment and real-estate subsidiaries

Understudied the Corporate Director.

Ampal-American Israel Corporation acquires interests in businesses located in Israel or that are Israeli-related. The Company and its subsidiaries have investments in high technology and communications, real estate, capital markets, leisure time, energy distribution, and industry.===🎯 Implement process improvements and action plans to drive improved financial performance🎯 Managing a timely delivery of my team's activities and ensuring a consistent and compliant approach🎯 Ensuring compliance and financial process and controls. Identifying areas of improvement🎯 Oversee compliance with contractual documentation and all agreed programs and procedures

PricewaterhouseCoopers is a multinational professional services network of firms, operating as partnerships under the PwC brand. PwC ranks as the second-largest professional services network in the world and is considered one of the Big Four accounting firms, along with Deloitte, EY, and KPMG.